Skip to main content
Fig. 2 | Nutrition Journal

Fig. 2

From: Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial

Fig. 2

Change in abdominal fat area after 12 weeks of intervention. Data are expressed as Mean ± SD. ♯:p < 0.05, ♯♯:p < 0.01 v.s. Placebo. n = 15 in each of groups except for Placebo (n = 14). GH glucosyl hesperidin 500 mg, Caf 25, 50, 75 caffeine 25 mg, 50 mg, 75 mg

Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us